PRESERFLO® MicroShunt Extension Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Palmberg, MD, PhD
Bascolm Palmer Eye Institute
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pôle Ophtalmologique de la Clinique Mutualiste
Pessac, Bordeaux, France
- A. O.U.P (azienda Ospedaliere Universitaria Pisana) Stabilimento Di Cisanello
Pisa, Cisanello, Italy
- Hospital Clínico San Carlos
Madrid, Spain
- Moorfields Eye Hospital
London, United Kingdom
- Arizona Advance Eye Research Institute, Llc.
Glendale, Arizona, United States
- Vold Vision
Fayetteville, Arkansas, United States
- Ucla Medical Center Jules Stein Eye Institute
Los Angeles, California, United States
- University of California at Davis Eye Center
Sacramento, California, United States
- Ophthalmic Consultants of Connecticut
Meriden, Connecticut, United States
- Intermountain Eye Center
Eagle, Idaho, United States
- Eugene and Marilyn Glick Eye Institute
Indianapolis, Indiana, United States
- Stiles Eye Care Excellence & Glaucoma Institute
Overland Park, Kansas, United States
- Minnesota Eye Consultants, Pa
Bloomington, Minnesota, United States
- New York Eye and Ear Infirmary of Mt. Sinai
New York, New York, United States
- Glaucoma Consultants of the Capital Region
Slingerlands, New York, United States
- Cincinnati Eye Institute
Cincinnati, Ohio, United States
- Ophthalmic Surgeons and Consultants of Ohio
Columbus, Ohio, United States
- Dean Mcgee Eye Institute
Oklahoma City, Oklahoma, United States
- Ophthalmic Partners of Pennsylvania
Bala-Cynwyd, Pennsylvania, United States
- Glaucoma Associates of Texas
Dallas, Texas, United States
- Ophthalmology Associates
Fort Worth, Texas, United States
- University Eye Associates
Houston, Texas, United States
- R&r Eye Research, Llc
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 May 2020
- Primary completion
- 24 Nov 2022
- Completion
- 24 Nov 2022
- Last update posted
- 22 Mar 2024
- Registered enrollment
- 279
- Registry id
- NCT04333433
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.